To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Myofascial Release Reduces Rate of Elbow Joint Bleeding in Hemophilic Elbow Arthropathy Patients

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
July 2021

Myofascial Release Reduces Rate of Elbow Joint Bleeding in Hemophilic Elbow Arthropathy Patients

Vol: 55| Issue: 1| Number:2| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Effects of myofascial release on frequency of joint bleedings, joint status, and joint pain in patients with hemophilic elbow arthropathy: A randomized, single-blind clinical trial

Medicine (Baltimore). 2021 May 21;100(20): e26025.

Contributing Authors:
R Cuesta-Barriuso R Pérez-Llanes E Donoso-Úbeda JA López-Pina J Meroño-Gallut

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Sixty-nine patients with hemophilic elbow arthropathy were included in this randomized controlled trial comparing 3 weeks of myofascial release therapy (n=35) to control (n=34) for the reduction of elbow joint hemarthrosis. The primary outcome of interest was the frequency of hemarthrosis. Secondary outcomes of interest included joint status on the hemophilia joint health score (HJHS) and joint pa...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue